<DOC>
	<DOCNO>NCT01715961</DOCNO>
	<brief_summary>This clinical trial multicentric prospective study assess clinical prognostic value sarcopenia patient older 70 year diffuse large B-cell lymphoma .</brief_summary>
	<brief_title>Clinical Prognostic Value Sarcopenia Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma</brief_title>
	<detailed_description>Sarcopenia status assess CT scan image overall survival 18 month patient older 70 year diffuse large B-cell lymphoma treat R-CHOP .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>Patients &gt; = 70 year DLBCL , grade IIIB follicular lymphoma histologically proven transform low grade lymphoma Whatever IPI score performance status Treated RituximabCHOP RituximabminiCHOP CT scan imaging perform one month less inclusion Signed informed consent No initial CT scan imaging perform one month inclusion Positivity HCV , HBV HIV Anthracycline contraindication</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>70 year old</keyword>
	<keyword>DLBCL</keyword>
	<keyword>Rituximab-CHOP</keyword>
	<keyword>Sarcopenia</keyword>
</DOC>